In circumstances where patients cover the cost of treatment, where reimbursement is restricted, or when insurance coverage is limited, the financial expense may influence selection of GLP-1 RA therapy [123]
some patients are afraid of needles, can't guarantee refrigeration due to frequent travel, or simply prefer a pill
DNG efficiently decreases circulating glucose in genOhGLP-1R model
This classification means they do not require FDA approval for safety or efficacy before marketing, and manufacturers cannot legally claim to diagnose, treat, cure, or prevent disease
A moderate dosage titration method is advised to mitigate adverse effects when commencing medication (Bettge et al
Selective Agonism Rather than activating receptors fully, some experimental medications partially activate them or activate specific subtypes